雅化集團(002497.SZ)所持金奧博股權質押融資款還款完畢並解除質押5184萬股
格隆匯 7 月 10日丨雅化集團(002497.SZ)公佈,2018年3月21日,公司將所持金奧博19.1%的股權共計2160萬股進行質押融資,融資金額為1.6億元。2020年5月29日,公司辦理了上述股權質押融資款部分提前還款手續,提前還款的金額為人民幣1億元。
2020年7月9日,公司辦理了上述股權質押剩餘全部融資款還款手續,還款金額為人民幣6000萬元。此次還款手續完成後,公司所持金奧博股權質押融資款已全部還款完畢,2020年7月10日,公司已完成所持金奧博股份的股權質押解除手續,此次解除質押5184萬股,佔公司所持金奧博股份比例100%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.